Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ibigen srl - flucloxacillin sodium - powder for solution for injection/infusion - 1000 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ibigen srl - flucloxacillin sodium - powder for solution for injection/infusion - 2000 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Australia - inglés - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - flucloxacillin sodium monohydrate, quantity: 2176 mg (equivalent: flucloxacillin, qty 2000 mg) - injection, powder for - excipient ingredients: - treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections including pneumonia, skin and skin structure and wound infections, infected burns and cellulitis.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

origen pharmaceuticals limited - flucloxacillin sodium monohydrate 25 mg/ml equivalent to flucloxacillin 25 mg/ml;   - powder for oral suspension - 125 mg/5ml - active: flucloxacillin sodium monohydrate 25 mg/ml equivalent to flucloxacillin 25 mg/ml  

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

medra & pharma services limited - flucloxacillin sodium monohydrate 272mg equivalent to flucloxacillin 250 mg;  ;  ;  ;   - capsule - 250 mg - active: flucloxacillin sodium monohydrate 272mg equivalent to flucloxacillin 250 mg         excipient: magnesium stearate

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

medra & pharma services limited - flucloxacillin sodium monohydrate 544mg equivalent to flucloxacillin 500 mg;  ;  ;  ;   - capsule - 500 mg - active: flucloxacillin sodium monohydrate 544mg equivalent to flucloxacillin 500 mg         excipient: magnesium stearate

Australia - inglés - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 545 mg (equivalent: flucloxacillin, qty 500 mg) - capsule, hard - excipient ingredients: povidone; titanium dioxide; purified talc; brilliant blue fcf; iron oxide red; magnesium stearate; iron oxide yellow; gelatin; microcrystalline cellulose; sodium starch glycollate - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 272.5 mg (equivalent: flucloxacillin, qty 250 mg) - capsule, hard - excipient ingredients: povidone; brilliant blue fcf; magnesium stearate; sodium starch glycollate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; microcrystalline cellulose; gelatin - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.